Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
1.850
-0.060 (-3.13%)
Jan 22, 2025, 10:30 AM EST - Market open
Incannex Healthcare Employees
Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.
Employees
9
Change
6
Growth
200.00%
Revenue / Employee
$9,556
Profits / Employee
-$2,572,556
Market Cap
32.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IXHL News
- 7 weeks ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Newsfile Corp
- 2 months ago - Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewsWire
- 3 months ago - Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL) - Newsfile Corp
- 4 months ago - Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 4 months ago - Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives - Newsfile Corp
- 6 months ago - FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - GlobeNewsWire
- 6 months ago - Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - GlobeNewsWire